Activation of GABAA and 5HT1A receptors in the raphe pallidus abolish the cardiovascular responses to stress in conscious rats by Le, Nhut Minh Pham
James Madison University
JMU Scholarly Commons
Masters Theses The Graduate School
Spring 5-7-2010
Activation of GABAA and 5HT1A receptors in the
raphe pallidus abolish the cardiovascular responses
to stress in conscious rats
Nhut Minh Pham Le
James Madison University
Follow this and additional works at: https://commons.lib.jmu.edu/master201019
Part of the Biology Commons
This Thesis is brought to you for free and open access by the The Graduate School at JMU Scholarly Commons. It has been accepted for inclusion in
Masters Theses by an authorized administrator of JMU Scholarly Commons. For more information, please contact dc_admin@jmu.edu.
Recommended Citation
Le, Nhut Minh Pham, "Activation of GABAA and 5HT1A receptors in the raphe pallidus abolish the cardiovascular responses to stress
in conscious rats" (2010). Masters Theses. 381.
https://commons.lib.jmu.edu/master201019/381
Activation of GABAA and 5HT1A Receptors in the Raphe Pallidus Abolish the 
Cardiovascular Responses to Stress In Conscious Rats 
Nhut Minh Pham Le 
 
 
 
 
 
 
 
 
A thesis submitted to the Graduate Faculty of 
 
JAMES MADISON UNIVERSITY 
 
In 
 
Partial Fulfillment of the Requirements 
 
for the degree of 
 
Master of Science 
 
 
 
Department of Biology 
 
 
 
 
 
 
 
May 2010 
 
 
 
ii 
Acknowledgements 
 Many individuals have assisted me either directly or indirectly in the completion 
of this thesis.  I owe an immeasurable amount of gratitude to my family and friends who 
have supported me through both my graduate and undergraduate years.  My friends have 
provided their moral support and tolerated my sense of humor and short attention span.  
My family gave me something to look forward to on those few weekends when I was 
able to go home.  Particularly, I would like to thank my niece and nephew, who keep my 
mind young despite reminding me of how old I am.  Additionally, my mother has always 
been there to provide her advice when needed. 
 The faculty of JMU was instrumental to my success and in allowing me to explore 
my interest.  I would like to thank my committee members, Dr. Justin Brown, Dr. Corey 
Cleland and Dr. Norm Garrison, who provided their time and effort in providing their 
thoughtful comments that were instrumental to the completion of this project.   Dr. Justin 
Brown, who has been absurdly patient with me for the last four years and have provided 
me with an unforgettable research experience.  Dr. Corey Cleland was invaluable in 
offering his advice as my undergraduate academic advisor in addition to being a 
committee member for both my undergraduate and graduate theses.  Dr. Norm Garrison 
has been painstakingly flexible as a member of committee. 
 
 
 
 
 
iii 
Table of Contents 
Acknowledgements..............................................................................................................ii 
List of Figures.....................................................................................................................iv 
Abstract...............................................................................................................................v 
Introduction..........................................................................................................................1 
 Overview..................................................................................................................1 
 Regulation of the Cardiovascular System................................................................2 
 Cardiovascular Responses to Stress.........................................................................3 
 The Role of Brainstem Serotonin in Cardiovascular Regulation.............................3 
 Clinical Implications................................................................................................7 
 Current Study.........................................................................................................11 
 
Materials and Methods.......................................................................................................14 
 
 Animal Use Rational..............................................................................................14 
 Animal Care...........................................................................................................14 
 Biotelemetry...........................................................................................................16 
 Stereotaxic Surgery................................................................................................16 
 Pharmacology........................................................................................................17 
 Data Collection......................................................................................................17 
 Experiments...........................................................................................................18 
 Histologic Verification...........................................................................................19 
 Statistical Analysis.................................................................................................22 
 
Results................................................................................................................................24 
 
 Baseline MAP and HR...........................................................................................24 
 Effects of Microinjections on Cardiovascular Responses to Stress.......................30 
 
Discussion..........................................................................................................................42 
 
 Basal Cardiovascular Parameters...........................................................................42 
 Inhibition of Brainstem Neurotransmission...........................................................43 
 Cardiovascular Responses to Stress.......................................................................43 
 Clinical Implications..............................................................................................50 
 Conclusions............................................................................................................52 
 
Bibliography......................................................................................................................53 
 
 
iv 
List of Figures 
Figure 1.  Projections of the rostral and caudal domains of serotonergic cells of the MR..6 
Figure 2.  Changes in the density of serotonergic neurons associated with SIDS..............9 
Figure 3.  Changes in the distribution of the 5HT1A receptor associated with SIDS.......10 
Figure 4. Experimental timeline........................................................................................15 
Figure 5.  Coronal section of the rat medulla at -2.0 mm relative to the interaural point..21 
Figure 6.  Baseline measures of MAP and HR prior to handling......................................25 
Figure 7.  Baseline measures of MAP and HR prior to air jet stress.................................27 
Figure 8.  Baseline measures of MAP and HR prior to handling stress............................29 
Figure 9.  Change in MAP in response to handling stress.................................................31 
Figure 10.  Change in HR in response to handling stress..................................................33 
Figure 11.  Change in MAP in response to air jet..............................................................35 
Figure 12.  Change in HR in response to air jet ................................................................37 
Figure 13. Change in MAP in response to restraint...........................................................39 
Figure 14.  Change in HR in response to restraint.............................................................41 
Figure 15.  Distribution of the 5HT1A receptor and tryptophan hydroxylase....................47 
Figure 16.  Possible mechanisms in which the 5HT1A receptors inhibits the SNS............48 
Figure 17.  The role of the serotonin system in the MR on stress responses and its    
        relationship to SIDS........................................................................................51 
 
 
 
 
v 
Abstract 
Serotonergic neurons of the raphe pallidus area of the brainstem are involved in the 
cardiovascular responses to stress.  However, the manner in which they mediate these 
responses is not well understood and severe abnormalities in this system have been 
associated with Sudden Infant Death Syndrome.  In the current study, microinjections of 
muscimol and 8-OH-DPAT (GABAA and 5HT1A receptor agonists, respectively) into the 
raphe pallidus abolished the increase in mean arterial pressure and the tachycardiac 
responses following air jet, handing, and restraint stress that were observed following 
microinjections of artificial cerebrospinal fluid.  The stress responses following muscimol 
microinjections suggest that this region of the brainstem was responsible for mediating 
cardiovascular responses to stress.  The result of DPAT microinjections suggests that 
within this region of the brainstem, the serotonin system is responsible for these 
responses.   
Introduction 
Overview 
 Serotonin (5-hydroxytrytamine; 5HT) is used as an intercellular messenger both 
in the central nervous system (CNS) and the periphery (Bijl 2004).  The 5HT system 
includes seven know families of receptors, with at least 14 distinct subtypes (Barnes & 
Sharp 1999).  Abnormalities in the 5HT system, particularly the brainstem, have been 
implicated in several pathologies including sudden infant death syndrome (SIDS) (Sahni 
et al. 2007; Paterson et al. 2006; Marzano et al. 2008; Sawaguchi et al. 2003), congenital 
central hypoventilation syndrome (Cutz el al. 1997; Saito et al. 1999; Weese-Mayer et al. 
2008), migraines (Hamel 2007), and several psychiatric disorders (Moore et al 2000).  
Additionally, serotonergic pathways in the brainstem have been found to be involved in 
coordination of autonomic functions including the regulation of the cardiovascular 
system (Karlsson et al. 2006; Gong et al. 2006), respiratory system (Doi et al. 2008), and 
nociception (Suzuki et al 2004; Bartsch et al. 2004). 
 The brainstem is situated between the spinal cord and higher cortical regions.  
Due to its location, numerous ascending and descending neural tracts must traverse the 
brainstem, and are subject to modulation by various brainstem nuclei.   Many of the 
nuclei in the brainstem contain populations of 5HT neurons such as the midline raphe 
nuclei (MR) (Marco et al. 1999), rostral ventral medulla (RVM) (Curran et al. 2007), and 
the nucleus tract solitarius (NTS) (Jeggo et al. 2005).  A recent study by Paterson et al. 
(2006) found extensive abnormalities in this system in infants that have died of SIDS.  
Specifically, there was a significant increase in the concentration of 5HT neurons in the 
brainstem coupled with a decrease in the concentration of the 5HT1A receptor, especially 
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in the MR.  These abnormalities may lead to an insufficient stress response and an 
increased risk for SIDS.   
Regulation of the Cardiovascular System 
 The body's regulation of the cardiovascular system involves both the CNS and 
peripheral systems.  The factor ultimately regulated in the cardiovascular system is 
arterial pressure (AP), which is a function of cardiac output (a function of heart rate (HR) 
and stroke volume) and vascular resistance (Guyenet 2006).  Short term control of the 
mean AP (MAP) is mediated by several regions of the brain (primarily the hypothalamus, 
rostral ventrolateral medulla (RVLM), and the nucleus of the solitary tract). The arterial 
baroreceptors help to sense rapid changes in MAP and make quick adjustment to enable 
short term stability of pressure around a set point.  Long term regulation of MAP is 
maintained by these brainstem structures as well as other organs such as the kidneys and 
select endocrine processes like the Renin- angiotensin-aldosterone system (Guyenet 
2006; Osborn 2005).  This endocrine system helps regulates MAP via controlling serum 
Na
+
 concentration.  Changes in Na
+
 concentration can lead to changes in blood volume 
and therefore changes in MAP.  Studies in both human and animal models have shown 
that the kidneys are able to maintain and, for the most part, prevent an increase in MAP 
in response to large increases in salt consumption by increasing natriuresis (sodium 
excretion) (Hall et al.1980; DeClue et al. 1978; Pechere-Bertschi et al. 2000). Therefore, 
regulation of MAP requires coordination between various organs and the sympathetic 
(SNS) and parasympathetic (PNS) nervous systems.  The brainstem is an essential 
component of these coordinated responses which enable survival of the organism.   
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Cardiovascular Responses to Stress 
 Although an organism's long term AP is regulated around a particular set point, 
short term changes in AP are normal.  AP, HR and SVR can fluctuate drastically from 
moment to moment.  These changes can be elicited by changes in posture, body 
movements, physical exertion or emotions (Guyenet 2006).  These changes are primarily 
adaptive as they allow the body to redirect blood flow to areas of the body that need more 
nutrients at any given time.  During stress, for example, MAP and HR can rise 
substantially above its basal levels to assure adequate blood flow to vital organs.  These 
changes are quick and primarily mediated by the sympathetic nervous system (SNS).  
Additionally, these cardiovascular responses occur in conjunction with changes in the 
respiratory system in anticipation of, or in response to, an increased oxygen demand (Jian 
et al. 2005).  Numerous regions of the brain have been implicated in these responses 
ranging from regions of the forebrain to those in the brainstem (Walker & Carrive 2003; 
Furlong & Carrive, 2007).   Recent studies have shown that activation of 5HT1A 
receptors in the MR area of the brainstem can attenuate cardiovascular responses elicited 
by activation of the hypothalamus (Horiuchi, Wakabayashi, & Hampney 2005; Horiuchi, 
McDowall, & Dampney, 2008). Therefore, pathways that help coordinate short term 
cardiovascular responses to stress appear to converge in the serotonin rich area of the 
MR.   
The Role of Brainstem Serotonin in Cardiovascular Regulation 
 Serotonin (5-hydroxytrytamine; 5HT) is found in both the vasculature as well as 
the CNS. (Yuwiler  et al 1977).   In the vasculature, it regulates vasomotor tone 
(therefore affecting blood pressure) and platelet aggregation (Rapport et al. 1948; 
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Azmitia et al. 1996).  Its role in the CNS involves the regulation of the cardiovascular 
system and other physiological processes, as well as cognitive functions including 
memory, emotions, and mood (Jacobs & Azmitia 1992).  When 5HT1A, the serotonin 
receptor of interest, is activated in the vasculature by administration of 8-hydroxy-2(di-n-
propylamino) tetralin (8-OH-DPAT; DPAT), a selective agonist, it generally has a 
negative effect on pressure. It also had bradycardic effects when administered 
systemically (Baire, Laubie, & Smith 1990, Di Francesco, Petty, & Fozard 1988; Gradin 
et al. 1985).  Clement and McCall (1990) found that these effects were due to inhibition 
of presympathetic neurons in the rostral ventrolateral medulla (RVLM).  These findings 
suggest a possible site in the brainstem of the depressive effects on the vasculature 
following global activation of the 5HT1A receptor. 
 Control of the cardiovascular system, especially stress responses, by the CNS 
originates in higher cortical regions of the brain as well as regions that regulate 
homeostasis.  Activation of the amygdala, insular cortex, and the hypothalamus have 
resulted in arrhythmias in rodent models (Nalivaiko 2006; Oppenheimer et al. 1991; 
Poisson, Christen, & Sannajust 2000).  These cortical pathways appear to converge in the 
brainstem before they are relayed to the rest of the body (Cao & Morrison 2003; Samuels, 
Zaretsky, & Dimicco 2002; Zaretsky et al. 2003).  The primary relay centers for 
cardiovascular responses in the brainstem are the RVLM and the MR, both of which are 
rich in serotonergic neurons.  The MR is a collection of neurons near the ventral surface 
of the brainstem that consists of the raphe pallidus (NRP), raphe magnus (NRM), and 
raphe obscurus (NRO).  These neurons have been implicated in the cardiovascular, 
thermoregulatory, pulmonary, and nociceptive responses to stress (Messier, Li, Nattie 
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2004; Cao & Morrison 2003; Fields & Anderson 1978; Morrison et al. 1999).  The rostral 
and caudal domains of the MR projects to different sites in the nervous system and have 
different functions (Figure 1).  The rostral domain projects to cortical regions of the brain 
and likely mediate afferent information to the cortex while the caudal domains projects to 
other brainstem regions and the spinal cord and likely mediate efferent responses from 
the brain (Kinney et al. 2009).    
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Figure 1.   Projections of the rostral and caudal domains of serotonergic cells of the 
MR.  Sagittal view of the human brain  showing the projections of serotonergic neurons 
of the MR.  Cells of the rostral domain of the raphe project towards cortical regions of the 
brain where as cells of the caudal domain project towards other brainstem regions and the 
spinal cord.  Cell bodies are represented by the red circles and projections are represented 
by the red arrows.  Adapted from Kinney et al. (2009). 
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  During a stress response, there is a coordination in the body to increase the 
activity of the SNS and decrease the activity of the PNS.  The role of brainstem 5HT in 
mediating stress responses has been documented in numerous studies and may enable this 
SNS activation and PNS inhibition.  Chemical activation of raphe neurons leads to 
activation of sympathetic responses such as tachycardia (Cao & Morrison 2003).  During 
a stress response, there is decreased activity of the Vagus nerve, indicating decreased 
PNS activity during a stress response (Nalivaiko & Sgoifo 2009).  The response of the 
Vagus nerve to stress can be suppressed by activation of the 5HT1A receptor in the 
MR(Ngampramuan et al. 2008).  Recent studies that examined the effects of 5HT1A 
receptors on psychological stress using the open field stress paradigm found that 
activation of the receptor reduces the cardiovascular response in four different strains of 
rats (van den Buuse & Wegener 2005).  Similar results were found by Vianna, Allen, and 
Carrive (2008) who blocked the responses to conditioned fear by chemical inhibition of 
the MR.  Studies using transgenic 5HT1A knockout models of mice found cardiovascular 
responses to be exacerbated when exposed to stressful stimuli (Gross et al 2000; Pattjj et 
al. 2002).  In the brainstem, the 5HT1A receptor has been found to inhibit the activity of 
the serotonin system which likely help to mediate cardiovascular responses to exogenous 
stress (Lundberg et al.  2007; Nalivaiko et al 2005).   
Clinical Implications 
 Understanding of the role of the brainstem 5HT system has large implications for 
human health.  Knowing the role of these systems allows for a better understanding of the 
neural circuitry that controls the physiological processes necessary for life.  This allows 
for a better understanding of what to expect when there are abnormalities in this system.  
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Numerous pathologies have been associated with abnormalities in the brainstem 5HT 
system.  The most notable in recent years has been Sudden Infant Death Syndrome 
(SIDS).  SIDS is the leading cause of infant mortality in the United States with an 
incidence rate of 0.67 per 1000 live births (Krous et al. 2004).  While its exact causes are 
still unknown, the 5HT system in the brainstem has been heavily implicated.  A study by 
Paterson et al. (2006) found numerous abnormalities with this system following autopsies 
of infants that have died of SIDS.  Specifically, there was an increase in the density of 
serotonergic neurons (Figure 2) and a decreased density of 5HT1A receptors in infants that 
died of SIDS compared to infants that died of other causes, especially in the MR (Figure 
3).   Recently, Duncan et al. (2010) found that the brainstems of infants that have died of 
SIDS had decreased concentrations of 5HT and trytophan hydroxylase, the enzyme 
responsible for the rate limiting step in the biosynthesis of serotonin.  These findings are 
consistent with adults who have been diagnosed with multiple system atrophy (MSA).  
Among patients with (MSA), serotonin depletion, especially of structures in the medulla, 
have been associated with sudden death compared to MSA patients that have died of 
known causes (Tada  et al. 2009). 
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Figure 2.  Changes in the density of serotonergic neurons associated with SIDS.  The 
density and distribution of serotonergic neurons in infants that died of SIDS compared to 
those that died of other causes.  Infants that have died of SIDS have a much higher 
density of serotonergic neurons, especially in the MR.  Adapted from Paterson et al 
(2006). 
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Figure 3.  Changes in the distribution of the 5HT1A receptor associated with SIDS.  
The density and distribution of 5HT1A receptors in infants that died of SIDS compared to 
those that died of other causes.  Receptor density was determined by its binding density 
to 8-OH-DPAT, a selective 5HT1A receptor agonist.  Infants that have died of SIDS have 
a reduced density of the 5HT1A receptor.  Adapted from Paterson et al (2006). 
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 Due to its role in regulation of the cardiovascular system, the brainstem 5HT 
system has also been implicated in hypertension, a major public health problem in the 
United States.  Although the mechanisms are not fully understood, the network of 
systems that regulate long term basal MAP appear to have an increase in its set point 
during hypertension (Guyenet 2006; Lechin & can der Dijs 2006).  A component of this 
network, hyperactivity of the brainstem 5HT system can lead to increased sympathetic 
activation and contribute to the increase in MAP. 
 Serotonin has been heavily implicated in mental disorders, particularly depression 
and anxiety.  A decrease in 5HT activity has been associated with depression and an 
increase in activity has been associated with anxiety.  These psychological factors have 
been associated with cardiac mortality, sudden cardiac death, and coronary artery disease 
(Bunker et al. 2003; Jonnakuty & Gragnoli 2008; Nalivaiko 2006).  Treatments of these 
disorders with drugs that affect the 5HT system are effective, but the complete 
mechanisms by which they are mediated have not been fully elucidated.   
Current Study 
 The role of the brainstem 5HT system in regulation of autonomic function 
suggests that it this area of the nervous system is important in controlling the 
physiological functions necessary for life.  Abnormalities in 5HT development in the 
brainstem which increase the risk for SIDS support this. However, its precise role in 
mediating physiological responses to stress has not been fully established.  Many studies 
examining the role of the 5HT1A receptor in the MR on the cardiovascular system have 
been attempted in the past however the use of anesthetized preparations have confounded 
the results.  When the 5HT1A receptor was activated in the nucleus of the raphé pallidus 
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(NRP) and raphé obscurus (NRO) of the brainstem, there were bradycardic responses and 
depressive effects on MAP in anesthetized animals (Coleman & Dampney 1995; McCall 
et al. 1987; Hof & Fozard 1989; Fozard et al. 1987).  However, studies in conscious 
animals found that these depressive responses were either much weaker or absent (Di 
Francesco et al.1988; Kolbasa et al.1991).  Thus the role of the MR 5HT1A receptors in 
mediation of cardiovascular responses to stress remains unclear.  
A recent study by Nalivaiko et al. (2005) found (using rabbits as a model animal) 
that the cardiovascular responses to several stressors were attenuated by the 
administration of 8-hydroxy-2(di-n-propylamino) tetralin (8-OH-DPAT), a selective 
agonist of the 5HT1A receptor.  However, the 8-OH-DPAT was microinjected into the 
fourth ventricle and 5HT1A receptors in a wide area may have been affected.  The MR 
was one of many areas of the brain affected, therefore the cardiovascular effects could 
not have been definitively attributed to the activation of 5HT1A receptors in the MR.  
Among the nuclei of the MR, the NRP is an area of interest due to abnormalities 
associated with this region in SIDS (Paterson et al.2006).  Previous studies has shown 
that the NRP is involved in regulation of the cardiovascular responses to stress 
(Alvarenga, Pires & Futuro Neto 2005; Coleman & Dampney 2006; Edwards & Paton 
2000; Zaretsky  et al. 2003).  However, its role in mediating cardiovascular has to be 
fully elucidated.  The NRP was targeted because it may serve as a model to study stress 
responses as it relates to SIDS.   
The intent of the present study is to determine if the NRP is responsible for the 
mediation of cardiovascular responses to exogenous stress.  The specific aims of this 
study are: 
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Specific Aim 1: To determine if the NRP is responsible in mediating the cardiovascular 
responses to exogenous stress.  To this end, muscimol, a gamma amino-butyric acid 
(GABA) agonist, will be used to non-selectively inhibit neurons of the NRP during mild 
stress induction. 
Specific Aim 2: To determine if these stress responses are mediated by the 5HT1A 
receptor.  The inhibitory 5HT1A receptors of the NRP will be activated with 8-OH-
DPATduring mild stress induction.  
Materials and Methods 
Animal Use Rational 
 Laboratory rats have been used extensively as an animal model in the study of 
mammalian physiology.  The rat 5HT1A receptor has 89% homology with the human 
analog (Albert et al. 1990) and its distribution in the brainstem is similar to that of a 
human (Burnet et al. 1995).  A recent study (Charkoudian et al. 2010) found that the 
cardiovascular system and the mechanisms by which they are controlled were 
qualitatively similar between rats and human.  This study will contribute both to the 
understanding of CNS regulation of the cardiovascular physiology and pathologies, such 
as SIDS and hypertension, that may develop when there are abnormalities within this 
system.  All methods were performed with approval from James Madison University’s 
animal care and use committee (IACUC).   
Animal Care 
 Male Sprague-Dawley rats were used for all parts of the study.  All rats were at 
least 9 weeks old and had a mass of 250g-375g.  All surgeries performed on rats were 
conducted using antiseptic techniques.  Specifically, incision sites were scrubbed with 
iodine, all surgical materials were sterilized, and the rat was placed on a sterile field.  
During surgeries (described below) animals were anesthetized with 75mg/kg ketamine 
and 15mg/kg xylazine with boosters as necessary.  Following surgeries, all animals were 
given 1mg/kg indomethacin on rat treats for pain control and a rest period of at least 1 
week before experimentation.  Both surgeries were done at the same time (for 
experimental timeline, see Figure 4). 
 
 Figure 4. Experimental timeline.  
cannula targeting the NRP and a telemetry prob
a resting period, 3 experiments were done on consecutive days (1 experiment/day).  
Following experimentation, the brains of the rats were fixed with 10% formalin for 
histology. 
 
 
 
 
 
 
 
 
 
Rats were instrumented with both an indwelling 
e that measured MAP and HR.  Following 
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Biotelemetry 
 A biotelemetry probe (PhysioTel PA-C40 small animal transmitter; DataSciences 
International; St. Paul, MN) was used to measure MAP and HR in the rats used for 
experiments.  PA-C40 probes have 2 parts- a catheter and probe body.  Rats were 
anesthetized and the abdominal region was shaved and scrubbed with iodine.  An incision 
(~1.5 inch) was made in order to access the peritoneal cavity and the descending aorta 
was exposed.  The descending aorta was separated from the inferior vena cava using 
gentle pressure from curved forceps and non-absorbable nylon sutures were inserted 
under the isolated aorta between the celiac and renal branches.  These sutures were used 
to momentarily stop the blood flow through the artery. 
In order to instrument the probe, a 23 gauge needle, bent ~90° at the tip, was used 
to pierce the occluded aorta in order to insert the catheter of the PA-C40 probes.  The 
aorta was repaired with tissue adhesive (LiquidVet Rapid; MedRep Express; Prescott, 
AZ).  A small piece of filter paper was used to increase surface area for adhesion and to 
hold the catheter in place.  Sutures were then removed to restore blood flow.  The probe 
body was sutured onto the abdominal muscles using non-absorbable silk sutures.  The 
abdominal muscle layer was closed with non-absorbable silk sutures and the skin was 
held together by autoclips. 
Stereotaxic Surgery 
 Stereotaxic surgery allowed for a cannula to be placed in the brainstem so that 
pharmacological manipulation of the NRP could later be performed using microinjection 
via a Hamilton syringe.  Immediately following instrumentation of the biotelemetry 
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probes, rats were placed in a stereotaxic frame.  The skin covering the skull was swabbed 
with iodine and an incision was made to expose the skull of the rat.  A hole was drilled on 
the rat’s skull -2.3mm caudal to lambda, where a 20 gauge stainless steel cannula, 26 mm 
long, was implanted -9.2 mm ventral to the skull surface where the hole was made.  The 
cannula was held in place with at least 3 screws that were placed into the rat’s skull and 
dental cement.   
Pharmacology 
 On the day of experimentation, a 25gauge, 28 mm long, cannula was used to 
deliver pharmacologically active ingredients to the NRP before the rats were stressed.  
Artificial cerebrospinal fluid (ACSF; 128 mM NaCl, 3.0 mM KCl, 1.3mM CaCl2, 1.0 Mg 
Cl2, 21.0 mM Na2HPO4, 1.3mM NaH2PO4, 1.0 mM D-glucose, pH=7.4 titrated by 
bubbling in CO2; McNay & Sherwin 2003) was used as a control and a basis for 
comparison to 8-OH-DPAT and muscimol.  Muscimol is an agonist for gamma-amino 
butyric acid (GABA) receptors, an inhibitory neurotransmitter.  For all experiments, 
300nL of ACSF, 30mM muscimol, or 30nM 8-OH-DPAT was injected into the NRP at a 
rate of 100nL/minute.  Immediately following microjections of these drugs, 100nL of air 
was injected and the injection cannula was left in the brain for 1 minute to allow the 
drugs to diffuse into the brain tissue and to prevent reflux of drug back through the 
injection cannula.   
Data Collection 
 Biotelemetry probes that had been instrumented into the rats allowed for 
continuous data collection without disturbing the animal.  The rat's cage was placed 
directly above receiver plates (RPC-1 receiver plates; DataSciences International; St. 
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Paul, MN) and data was collected every 30 seconds.  Each time data was collected, HR 
and MAP data was sampled for 10 seconds and automatically averaged by the software 
(Dataquest A.R.T.; DataSciences International; St. Paul, MN).  Data was recorded for at 
least 15 minutes prior to the rat's cage being opened for microinjections and at least 15 
minutes after the end of a stress.  The 15 minutes prior to microinjections were averaged 
and used as a baseline measure.  The rat's baseline HR and MAP were subtracted from 
values after they were stressed to obtain the change in the respective parameters.  Data 
from the point the rat's cage was opened until the end of the stress was not used for 
analysis due to the effect of the microinjection protocol on the animal. 
Experiments 
 Prior to microinjections, all rats were allowed to acclimate in its cage until its 
MAP (remained within ± 5 mmHg) and HR (remained within ± 25 beats per minute 
(bpm)) has stabilized for at least 15 minutes.  All experiments were conducted in the rat's 
home cage.  No more than 3 stress experiments were conducted on each rat.  Only one 
experiment was conducted per day, and experiments were conducted on consecutive 
days.  The order in which drug or stress was done each experiment was randomized.  
Immediately following microinjections, rats were stressed as described below: 
Handling:  Rats are handled on a regular basis - transfer to a new cage, experiments, etc.   
These experiments tested the rat's responses to a stress that they have been familiar with.  
The rats were held at approximately the midpoint of the tail for 30 seconds.  After 30 
seconds, they were released and the lid of the cage was replaced. 
Air Jet: The air jet stress have been used in previous studies (Nalivaiko 2005) as an 
"acute psychological" stress.  This stress is novel to the animal and it may be difficult for 
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them to interpret what is happening.  During the air jet stress, the rats were allowed to 
freely move around the cage and filter tops were kept in place.  A nozzle attached to a 
canister of compressed air was inserted into the cage and a continuous jet of air was 
injected into the cage for 60 seconds.  The nozzle was aimed at the rat during the course 
of the stress. 
 Restraint: Rats in a laboratory setting are rarely restrained, except in circumstances 
where it may be deemed necessary for experimental protocols or surgical preparations.  
In nature, restraint usually means that it had been captured by a predator.  Such instances 
would elicit full activation of the "fight or flight" response.  This stress was meant to 
achieve such a response.  Specifically, these rats were held (with handlers wearing a 
leather glove) in the thoracic region behind the front limbs.  While the rats were able to 
move their limbs, they were not able to move their bodies, and were held in place for 60 
seconds. 
Histologic Verification  
 After experiments were completed, the rats were sacrificed to verify that the 
cannula was placed in the NRP during the stereotaxic surgery.  Prior to sacrificing with 
isofluorane, 300 nL of a 1% solution of potassium permanganate was microinjected into 
the brainstem of the rats (in the same manner as the pharmacologically active drugs).  
Potassium permanganate stains the brain tissue where the pharmacologically active 
agents were microinjected.  The heart will be exposed and the jugular vein cut.  A needle 
was inserted into the left ventricle of the heart and perfused with 200 mL saline or until 
the fluid coming out of the jugular vein is clear.  Following perfusion by saline, the rats 
were fixed with 200mL 4% formalin.  The brains were extracted and placed into a jar 
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with 10% formalin for at least 4 days.  Once the brains were fully fixed, they were placed 
into a jar containing approximately 30% sucrose until it is saturated with sucrose, 
evidenced by the brain sinking to the bottom of the solution (approximately 4-5 days).  
The brain tissue will then be mounted onto a cryostat and cut into 50 µm sections and set 
onto glass slides.  Slides were dried, stained with cresyl violet, and covered with a cover 
slip using Permount® adhesive.  Stain on the tissue will be compared to areas of the brain 
identified as the NRP in the sterotaxic atlas (Paxinos & Watson 1998).  Stereotaxic 
targeting of the NRP will be deemed successful if there is staining by potassium 
permanganate within 1.0 mm of the ventral surface, 1.5 mm rostral/caudal to the caudal 
aspect of the facial nucleus, and within 0.5 mm of the midline as indicated by comparison 
to the stereotaxic atlas (Figure 5).  Only rats with injection marks within these parameters 
were used for statistical analysis. 
 
 
 
 
 
 
 
 
 
 Figure 5. Coronal section of the rat medulla at 
point.  A histological section (right) is compared to a stereotaxic map of the rat brain 
(left).  The facial nuclei are outlined in blue.  On the left, the NRP is re
red mark (Adapted from Paxinos & Watson 1998).  On the right, the injection site is 
outlined in red. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-2.00 mm relative to the interaural 
presented by the 
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 Staining of the brain sections with cresyl violet were done according to the 
following conventional protocol: 
1. Tissue dehydration: Brain sections on glass slides were placed into solutions of 
increasing concentrations of ethanol (50%, 70%, 90%, and 100%.) for 5 minutes in each 
solution.   
2. Dehydrated brain sections were placed into 100 % xylene for 5 minutes. 
3. The brain sections were returned to 100% ethanol for 5 minutes after soaking in 
xylene. 
4. Brain sections were stained in a 1% cresyl violet solution at ~60ºC for 6 minutes. 
5. Stained brain sections were dipped into dH2O. 
6. Brain sections were then destained for visualization of brain structures: 
 a. Sections were soaked in 50% ethanol for 5 minutes. 
 b. Destaining was done in 70% ethanol with 5 drops of acetic acid. 
 c. Destained brain sections were dehydrated in 90% and 100% ethanol as stated 
above. 
7. Destained brain sections were fixed in xylene overnight.  The following day, permount 
and a coverslip was placed over slides. 
Statistical Analysis 
 Raw MAP and HR data were averaged into 3 minute bins for each rat.  An 
analysis of variance (ANOVA) was conducted at each 3 minute bin between each 
treatment to determine if there was a statistical difference between each treatment group 
for each time segment.  Tukey-HSD was conducted as a post-hoc test to determine if 
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there were differences between individual groups at each time point.  All reported data 
are means ± standard error with a level of significance standard of p<0.05. 
Results 
 In most instances, statistical analysis of the data revealed that the change in the 
MAP and HR of rats in the DPAT and muscimol treatment groups were not statistically 
different from pre handling base line. There was also no significance in the post handling 
treatment effect on HR or MAP between DPAT and Muscimol injected rats.  Most 
importantly, changes in MAP and HR of rats microinjected with ACSF were usually 
statistically different (p<0.05) than both pre stress base line and those responses from rats 
microinjected with DPAT or muscimol.  Please assume this was the case unless otherwise 
noted. 
Baseline MAP and HR 
 Rats that were handled had MAP of 107±2.99 (range 95.8-117), 114±4.07 (range 
102-130), and 110±7.55 (range 92.9-141) mmHg and HR of 325±13.9 (range 295-388), 
327±13.3 (range 305-391), and 330±8.30 (range 305-354) bpm for the ACSF, DPAT, and 
muscimol microinjected treatments, respectively (Figure 6).  ANOVA analysis of pre 
treatment values revealed that neither MAP (p=0.69) nor HR (p=0.96) were significantly 
different in rats exposed to handling stress. 
 
 Figure 6. Baseline measures of MAP and HR prior to handling.  
MAP and HR in rats that were stressed by handling.  There were no significant 
differences.  
 
 
 
 
 
 
 
 
 
 
 
Baseline measures of 
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 Rats that were stressed using an air jet had MAP of 110±3.67 (range 96.3-119), 
113±6.76 (range 93.2-141), and 109±3.06 (range 103-119) mmHg and HR of 304±22.7 
(range 199-354), 298±26.6 (range 199-350), and 310±16.2 (range 244-368) bpm for the 
ACSF, DPAT, and muscimol microinjected treatments, respectively (Figure 7).  ANOVA 
analysis of pre treatment values revealed that neither MAP (p=0.84) nor HR (p=0.08) 
were significantly different in rats exposed to air jet stress. 
 
 
 
 
 
 
 
 
 Figure 7.  Baseline measures of MAP and HR prior to air jet stress. 
measures of MAP and HR in rats that were stressed by air jet.  There were no significant 
differences.  
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 Rats that were restrained had MAP of 116±6.25 (range 96.8-138), 114±9.40 
(range 92.9-143), and 108±3.66 (range 98.6-121) mmHg and HR of 314±4.37 (range 
306-330), 322±10.2 (range 294-361), and 312±22.0 (range 243-361) bpm for the ACSF, 
DPAT, and muscimol microinjected treatments, respectively (Figure 8).  ANOVA 
analysis of pre treatment values determined that neither MAP (p=0.70) nor HR (p=0.88) 
were significantly different in rats exposed to air jet stress. 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 8. Baseline measures of MAP and HR prior to restraint stress.  
measures of MAP and HR in rats that were restrained.  There were no significant 
differences.  
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The Effect of Microinjections on Cardiovascular Responses to stress 
Handling Stress 
 Rats were handled in order to assess their cardiovascular response to a familiar 
stress.  The change in MAP at 3, 6, 9, 12, and 15 minutes after handling was 14.8±2.88, 
12.9±4.36, 12.6±3.62, 11.3±3.80, and 12.0±3.82 mmHg for ACSF microinjected rats, 
2.60±2.19, 0.81±2.36, 0.39±3.03, -1.53±2.95, and -2.84±3.68 mmHg following DPAT 
microinjected rats, and -0.03±2.43, -1.19±2.40, -1.83±3.24, 1.73±4.60, and -0.33±4.11 
mmHg for muscimol microinjected rats respectively (Figure 9).  ANOVA with post hoc 
analysis revealed significant differences between ACSF and both muscimol and DPAT 
microinjections at 3 (p=0.002), 6 (p=0.014), 9 (p=0.016), and 15 (p=0.036) minute 
averages, but not at the 12 minute average (p=0.079). At 15 minutes, the difference 
between ACSF and muscimol microinjected groups were not statistically significant 
(p=0.096).  
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Figure 9.  Change in MAP in response to handling.  The change in MAP in response 
to handling stress.  * Denotes statistical difference. 
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 The changes in HR at 3, 6, 9, 12, and 15 minutes following handling were 
76.9±13.7, 52.8±8.47, 44.6±6.85, 47.2±11.8, and 52.4±11.4 bpm for ACSF microinjected 
rats, -5.68±9.42, -10.9±9.67, -4.05±12.3, -10.5±9.99, and -11.2±11.0 bpm for DPAT 
microinjected rats, and -2.63±7.17, -17.9±8.78, -18.62±13.8, -17.6±15.7, and -12.2±15.13 
mmHg for muscimol microinjected rats, respectively (Figure 10).  ANOVA analysis with 
post hoc analysis revealed that these differences were statistically different at 3 
(p<0.001), 6 (p<0.001), 9 (p=0.003), 12 (p=0.005), and 15 (p=0.003) minute averages. 
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Figure 10.  Change in HR in response to handling.  The change in HR in response to 
handling stress.  * Denotes statistical difference. 
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Air Jet Stress 
 The air jet stress was used to assess the rats’ response to a novel stress. The 
change in MAP at 3, 6, 9, 12, and 15 minutes following the air jet stress were 14.0±2.88, 
11.0±2.93, 10.0±2.66, 10.3±3.45, and 8.90±3.43 mmHg for ACSF microinjected rats,  
-5.62±1.68, -8.35±1.02, -7.30±1.43, -7.93±1.54, and -7.18±1.38 mmHg for DPAT 
microinjected rats, and -2.81±4.38, -6.53±4.89, -7.51±4.51, -9.16±5.27, and -11.3±6.31 
mmHg for muscimol microinjected rats, respectively (Figure 11).  ANOVA analysis with 
post hoc analysis revealed that these differences were statistically different at 3 
(p=0.001), 6 (p=0.002), 9 (p=0.002), 12 (p=0.003), and 15 (p=0.010) minute averages.  
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Figure 11.  Change in MAP in response to air jet.  The change in MAP in response to 
air jet stress.  * Denotes statistical difference. 
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 The change in HR at 3, 6, 9, 12, and 15 minutes following air jet stress were 
41.6±13.9, 37.1±9.86, 36.2±9.83, 39.7±12.7, and 37.5±12.5 bpm for ACSF microinjected 
rats, -34.9±10.1, -35.2±8.17, -30.1±9.63, -26.6±14.6, and -24.8±16.5 bpm for DPAT 
microinjected rats, and -20.1±15.5, -19.0±14.1, -20.3±11.4, -17.3±10.7, and -31.6±10.1 
mmHg for muscimol microinjected rats, respectively (Figure 12).  ANOVA with post hoc 
analysis revealed that these differences were statistically different at 3 (p=0.002), 
6(p=0.001), 9 (p=0.001), 12(p=0.005), and 15 (p=0.002) minute averages.  
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Figure 12.  Change in HR in response to air jet.  The change in HR in response to air 
jet stress.  * Denotes statistical difference. 
 
 
 
 
 
 
 
 
 
38 
 
Restraint Stress 
 The restraint stress was used to elicit the rat to fully activate its “fight or flight” 
response. The changes in MAP at 3, 6, 9, 12, and 15 minutes following the restraint stress 
were 15.7±5.17, 18.7±6.73, 18.7±7.7, 19.1±6.31, and 20.3±8.31 mmHg for ACSF 
microinjected rats, 6.01±1.83, 0.11±1.73, -0.20±2.35, 1.01±3.78, and -0.25±3.67 mmHg 
for DPAT microinjected rats, and -3.08±2.82, -8.67±3.28, -11.2±3.58, -10.6±4.41, and -
12.7±4.22 mmHg for muscimol microinjected rats, respectively (Figure 13).  ANOVA 
with post hoc analysis revealed that these differences were statistically different at 3 
(p=0.001), 6 (p=0.002), 9 (p=0.002), 12 (p=0.003), and 15 (p=0.010) minute averages.  
At 3 (p=0.164), 12 (p=0.052) and 15 (p=0.059) minutes, the difference between ACSF 
and DPAT microinjected groups were not statistically significant. 
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Figure 13.  Change in MAP in response to restraint.  The change in MAP in response 
to restraint.  * Denotes statistical difference. 
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 The change in HR at 3, 6, 9, 12, and 15 minutes following restraint were 
69.1±20.5, 69.7±23.1, 78.7±18.5, 85.0±16.9, and 75.4±15.9 bpm for ACSF microinjected 
rats, 1.77±16.8, -11.6±7.63, -1.68±12.2, 5.32±16.1, and -1.57±16.7 bpm for DPAT 
microinjected rats, and -32.6±16.2, -36.7±15.4, -47.4±15.2, -50.4±15.4, and -49.7±15.7 
mmHg for muscimol microinjected rats, respectively (Figure 14).  ANOVA analysis 
revealed that these differences were statistically different at 3 (p=0.004), 6 (p=0.004), 9 
(p<0.001), 12 (p<0.001), and 15 (p<0.001) minute averages.  
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Figure 14.  Change in HR in response to restraint.  The change in HR in response to 
restraint.  * Denotes statistical difference. 
Discussion 
 During a stress response, there is usually a large increase in HR and moderate 
change in MAP.  This study found that these responses were abolished by microinjections 
of muscimol and DPAT into the NRP.  The lack of elevation in HR and MAP following 
microinjections of muscimol suggest that the NRP is responsible for normal elevations in 
HR and MAP.  The abolition of the cardiovascular responses to stress following 
microinjections of DPAT suggests that these responses were largely mediated by the 
serotonin system.  Additionally, this study was conducted in conscious rats.  Previous 
research in this area has involved the use of anesthetized animals, which have 
confounded the data concerning the role of the NRP in regulation of the cardiovascular 
system (Coleman & Dampney 1995; McCall et al. 1987; Hof & Fozard 1989; Fozard et 
al. 1987). Therefore, this study has more direct application to how the cardiovascular 
system responds to stress in a normal animal and how alterations in this system may 
contribute to the etiology of SIDS. 
Basal Cardiovascular Parameters 
 The pre stress MAP and HR of rats in the different microinjection treatments for 
each stress were not statistically different from each other.  However, there was a wide 
range of basal MAP and HR values within each group.  For example, the MAP of rats 
that were restrained had ranges of 96.8-138, 92.9-143, and 98.6-121 mmHg for the 
ACSF, DPAT and muscimol microinjected treatments, respectively.  The variation in 
these variables are similar to the results of Charkoudian et al. (2010), whose study 
examined the intraspecies variation of cardiovascular parameters of rats and humans.  
Baseline HR and MAP parameters were similar to those in previous studies (Vianna, 
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Allen, & Carrive 2008; van den Buuse & Wegener 2005).  The qualitative similarities 
between the cardiovascular systems of the rat and human reinforce the validity of the 
application of animal models to the study of human physiology. 
Inhibition of Brainstem Neurotransmission 
 Muscimol inhibits neuronal cells by activating GABAA receptors that increases 
the permeability of chloride channels.  Administration of muscimol likely activates 
inhibitory post synaptic receptors which decreases neuronal transmission. The inhibitory 
activity of the serotonergic system by activation of the 5HT1A receptor stems from its role 
as an autoreceptor and/or as a post synaptic inhibitory receptor.  Activation of this 
receptor has been found to inhibit the activity of adenylyl cyclase (Markstein et al 1986; 
Fayolle et al. 1988).  The reduced intracellular concentration of cyclic adenosine 
monophosphate (cAMP) stemming from this inhibition leads to a decrease in the activity 
of protein kinase A (PKA), which is activated by cAMP.   This leads to decreased 
stimulation of post synaptic cell (source) or inhibition of pre synaptic voltage-sensitive 
calcium channels, which are necessary for the exocytosis of synaptic vesicles (Dolphin 
2003).  The end result of 5HT1A receptor activation is the inhibition of post synaptic 
neuronal firing and/or inhibition of exocytosis of synaptic vesicles containing serotonin.   
Cardiovascular Responses to Stress 
 ACSF was used as a control in this study compared to studies that have used 
saline.  Cerebrospinal fluid is a complex solution of ions, nutrients, and proteins, all of 
which act as solutes and may be necessary for signaling events.  The use of saline may 
not have sufficient solutes and may cause cells in microinjected areas to swell (McNay & 
Sherwin 2003). 
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 In all instances, rats that were microinjected with ACSF and stressed had 
increases in MAP and HR.  However, the responses following the air jet stress was 
markedly lower than responses following the handling and restraint stress.  This 
difference may reflect either the different nature of this stress compared to the other 
stressors or it may be due to the rats' perception of the stress.  In both the handling and 
restraint stresses, the rats were physically touched and the cage top was opened, which 
may have set off different pathways in the brain upstream to the MR.  During the air jet 
stress, the cage top was not opened and the rat was not handled.  While the rat may have 
been stressed due to its uncertainty of the situation, it may have perceived the stress as 
environmental and not from a potential predator.  The fear of predation, which can be 
tested using the open field test, has been shown to trigger cardiovascular responses (van 
den Buuse & Wegener).  The differences in the magnitude of these responses could also 
be attributed to differences in the magnitude at which the neural centers that mediate the 
cardiovascular responses to stress were activated. 
 The increase in HR and MAP are the cardiovascular components in a 
multifactorial response to stress. The changes in these factors following microinjections 
of ACSF and stress indicated that neurons within the NRPs were intact and functional.  
The increases in MAP and HR are adaptive responses that allow for increased blood 
supply (and nutrients) to areas of the body (such as muscles) that would be used during 
stress.  This may translate to an increase in an animal's ability to escape from a predator 
or ability to fend its territory from competitors. 
 Changes in MAP and HR following stress in animals microinjected with DPAT 
and muscimol were statistically different from those microinjected with ACSF (with a 
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few exceptions).  The rats either had no change or a decrease in their cardiovascular 
parameters after stress following microinjections with DPAT or muscimol.  Activation of 
GABAA receptors inhibited the activity of the entire NRP.  This likely inhibited SNS 
premotor neurons in the NRP, and led to an inhibition of the SNS response to stress 
(Coleman & Dampney 1995).  DPAT inhibited the cardiovascular responses in a similar 
fashion to muscimol.  The neurons of the NRP are usually only active in response to 
stress (Nalivaiko, Ootska & Blessings 2005; Zaretsky et al. 2003).  Activation of the 
5HT1A receptors by DPAT inhibited the release of serotonin by these neurons.  The end 
result of microinjections of DPAT and muscimol were the same- SNS premotor neurons 
in the NRP were not activated.   
 The responses following microinjections of muscimol and DPAT were not 
significantly different from each other.  This suggests that these responses are entirely 
mediated by the serotonin system in the NRP or that the 5HT1A receptor can modulate 
other neurotransmitter systems in this region of the brain.   Muscimol generated IPSPs on 
post-synaptic cells to inhibit action potentials generated by other signaling pathways 
(such as serotonin).  DPAT likely inhibited the release of serotonin from pre-synaptic 
cells by activating autoreceptors, preventing the initiation of these action potentials.  
Alternatively, DPAT may have activated inhibitory post synaptic receptors that 
modulated the stress response.  The 5HT1A receptor is expressed pre- and post-
synaptically.  When expressed as a pre-synaptic autoreceptor, activation of the 5HT1A 
receptor inhibits the cell from releasing 5HT into the synaptic cleft. 5HT1A receptor is 
also found post-synaptically, mostly on the cell body and dendrites (Figure 15; Barnes & 
Sharp 1999, Darnall et al. 2005).  Its role on post-synaptic neurons has not been 
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extensively studied and is not well understood.  Given its role as a metabotrophic 
receptor, it cannot initiate an action potentials or IPSPs.  Perhaps the 5HT1A receptor has 
a modulatory effect when expressed post-synaptically.  Other excitatory 
neurotransmitters, namely glutamate and dopamine, in the MR have been identified as 
being partially responsible in mediating the cardiovascular responses to stress 
(Alvarenga, Pires & Futuro Neto 2005; Edwards & Paton 2000; Kitahama et al. 2000; 
Vianna, Allen, & Carrive 2008).  If microinjections of DPAT only affected the 5HT 
system, one would expect to see the effects of these other neurotransmitter systems, such 
as glutamate or dopamine that should have been activated during the stress response.  
Since the responses were abolished, it could be hypothesized that post-synaptic activation 
of the 5HT1A receptor may have affected the activity of those non-serotonergic 
neurotransmitter systems.  Although this has not been confirmed in the NRP, the 5HT1A 
receptor has been found to be a modulator of other neurotransmitters (Figure 16; Khateb 
et al. 1993). 
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Figure 15.  Distribution of the 5HT1A receptor and tryptophan hydroxylase.  Cells 
from the Nucleus Paragigantocellularis Lateralis were stained for the expression of the 
5HT1A receptor and tryptophan hydroxylase.  (A) Cells stained red were positive for 
tryptophan hydroxylase.  (B) Cells stained green were positive for the 5HT1A receptor.  
(C) An overlay of images A and B.  Orange cells expressed both the 5HT1A receptor and 
tryptophan hydroxylase.   Adapted from Darnall et al (2005). 
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Figure 16.  Possible mechanisms in which the 5HT1A receptors in the NRP inhibits 
the SNS.  A proposed role for 5HT1A in mediation of the SNS.  As an autoreceptor, the 
receptor inhibits the activity of serotonergic neurons.  As a post-synaptic receptor, it acts 
as an inhibitory modulator of other neurotransmitter systems.  Activation of the 
serotonergic and other neurotransmitter systems in the NRP activates the SNS, which 
goes on to activate stress responses.  This response is inhibited by the 5HT1A receptor. 
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While the abolishment of the normal cardiovascular response to stress following 
muscimol or DPAT injection is consistent with previous studies (Nalivaiko et al. 2005; 
Vianna, Allen, & Carrive 2008), there were noted differences.  These previous studies 
have generally found that microinjections DPAT, muscimol, and other inhibitory 
pharmacologic agents into the MR attenuated, but did not abolish, the cardiovascular 
responses to stress.  Generally, a response was still observed following microinjections 
and subsequent stress.  A difference in this study compared to others is that the rats were 
microinjected in their home cage without being picked up.  In previous studies, these 
animals were picked up and handled during microinjection.  Taken together, this suggests 
not only that these stress responses were mediated by the MR, but also that the entirety of 
the response may be mediated by the 5HT system.   
 An important issue arises when comparing the results of this study to previous 
studies.  Even though the animals were stressed in these previous studies, why were the 
cardiovascular responses not abolished as observed in this study (Nalivaiko et al. 2005; 
Vianna, Allen, & Carrive 2008)?  Why was only an attenuation of the response observed?  
A suitable explanation may be that as these animals were picked up and handled for 
microinjection, the fight or flight response may have been fully engaged.  The result of 
which may have been the release of hormones, including epinephrine, into the 
vasculature.  In turn, the attenuated response may be due to an abolishment of the neural 
aspect of the response and the hormonal effects may have already been established.  
Since the rats were not handled during microinjections in this study, the fight or flight 
response may have been abolished altogether.  The MR is a relay center for the 
descending stress signals from higher regions of the brain before they are relayed to the 
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body (Cao & Morrison 2003; Samuels, Zaretsky, & Dimicco 2002; Zaretsky et al. 2003).  
If instead of not only mediating the cardiovascular responses to stress, the MR also 
mediated the release of stress hormones into the vasculature, the differences between this 
study and the attenuated responses in previous studies could be accounted for.  However, 
this explanation is only a proposed hypothesis and would need to be verified 
experimentally. 
Clinical Implications  
 This study further expanded the understanding of the physiology of the MR and 
its role in regulating the cardiovascular responses to stress.  If the MR is the central relay 
station of the brain before these signals are sent to the body, it can aid in the explanation 
of the etiology of SIDS.  In SIDS, there are severe abnormalities in the 5HT system of the 
MR including the NRP.  These abnormalities can lead a loss of the ability for stress 
signals from the brain to reach the body.  Ultimately, this leads to an inability for the 
body to respond to stress that the brain may have detected, and subsequently to sudden 
death.  While this is a possible mechanism for sudden death, it is a downstream effect of 
the biological cause of SIDS (Figure 16). 
 
 
 
 
 
 
 
51 
 
 
 
Figure 17. The role of the serotonin system in the MR on stress responses and its 
relationship to SIDS. (A) Under normal circumstances, stress leads to an activation of 
the serotonergic system of the MR, which leads to a stress response.  (B)  When the 
serotonergic system of the MR is abnormal, the response to stress is not activated.  In 
infants, this leads to SIDS. 
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 Patients who have hypertension may have an increase in the body's set point for 
regulation of MAP (Guyenet 2006; Osborn 2005).  The MR is a cardiovascular control 
center and may potentially be partially responsible for the increase in set-point.  
Therapeutics that can selectively inhibit the 5HT system of the MR may be efficient in 
lowering the patient's MAP, however, the fidelity in the cardiovascular response to stress 
may be dangerously muted. 
Conclusions 
 Microinjections of muscimol and DPAT into the NRP abolished cardiovascular 
stress responses that were seen in rats that were microinjected with ACSF.  While this 
study provided insights into the mediation of cardiovascular responses to stress by the 
MR, it also posed new questions its mechanisms of action.  It is possible that instead of 
being responsible solely for the cardiovascular response to stress, the MR may be 
responsible for the mediating many more components of the stress response, including 
the hormonal components.  The loss of this response may be partially responsible for 
SIDS. 
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